Invention Grant
![Triazolo[4,5-d]pyrimidine derivatives](/docs/US/2016-08-09/US09409914B2/abs.jpg.600x600.jpg)
- Patent Title: Triazolo[4,5-d]pyrimidine derivatives
- Patent Title (中): 三唑并[4,5-d]嘧啶衍生物
-
Application No.: US14375067Application Date: 2012-12-21
-
Publication No.: US09409914B2Publication Date: 2016-08-09
- Inventor: Dieter Dorsch , Guenter Hoelzemann , Kai Schiemann , Ansgar Wegener
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano & Branigan
- Priority: EP12000558 20120128
- International Application: PCT/EP2012/005358 WO 20121221
- International Announcement: WO2013/110309 WO 20130801
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D471/00 ; C07D487/00 ; C07D491/00 ; C07D487/04 ; A61K31/5377
![Triazolo[4,5-d]pyrimidine derivatives](/abs-image/US/2016/08/09/US09409914B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of the formula I in which R1 and R2 have the meanings indicated in Claim 1, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.
Public/Granted literature
- US20140378431A1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES Public/Granted day:2014-12-25
Information query
IPC分类:
